Objectives
==========

Retrospective evaluation of the mammographic appearance of nonpalpable breast cancers and correlation with apoptosis-related factors.

Method
======

Patients with nonpalpable breast lesions (*n* = 211) were evaluated between 1989 and 1999. All patients underwent preoperative mammographically guided needle-excision biopsy. Specimen radiography was always followed. Histological examination revealed 55 cancers (26%; 30 ductal invasive \[54.5%\], 18 ductal *in situ* \[32.7%\], five lobular invasive \[9%\] and two lobular *in situ* \[3.8%\]). In 41 out of 55 carcinomas, immunohistochemistry was conducted, using monoclonal antibodies against bcl-2, fas and DNA fragmentation, and polyclonal antibody for bax.

Results
=======

Mammography revealed malignant microcalcifications in 42 out of 55 patients (76%) and opacity with undefined borders (greater diameter \<1cm) in 13 out of 55 patients (24%). In 16 out of 41 carcinomas (41%) there was immunostain positivity for bcl-2. In seven out of 16 patients (17.5%) mammography showed microcalcifications, whereas opacity was observed in nine out of 16 patients (22.5%). Twenty-three out of 41 carcinomas (56%) were positive for fas. In 14 out of 23 patients (60%) mammography showed microcalcifications and opacity in 11 out of 23 (47%). Thirty out of 41 carcinomas (73%) were positive for bax and DNA fragmentation. In 17 out of 30 (58%) carcinomas that were positive for DNA fragmentation, mammography showed microcalcifica-tions, whereas opacity was revealed in 16 out of 30 (53%) patients. In 18 out of 30 (60%) carcinomas that were positive for bax, mammography showed microcalcifications, whereas opacity was detected in 14 out of 30 (46%) carcinomas.

Conclusion
==========

Our results suggest the existence of significant correlation between mammographic appearance and expression of apoptosis factors in nonpalpable breast cancers, although the number of patients evaluated was relatively small.
